documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

10 rows where docket_id = "FDA-2006-N-0238" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 5

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-N-0238-0028 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Expanded Access to Investigational Drugs for Treatment Use Notice NAL-Notice of Approval 2011-03-03T05:00:00Z 2011 3 2011-03-03T05:00:00Z   2015-06-02T17:59:33Z 2011-04739 0 0 0900006480bfe012
FDA-2006-N-0238-0027 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 OMB Review [12866], Expanded Access to INDs, Final Rule Published 8/13/09 Other References (internal) (REF) 2009-08-24T04:00:00Z 2009 8 2009-08-24T04:00:00Z   2025-04-11T22:14:10Z   0 0 0900006480a0c8f0
FDA-2006-N-0238-0026 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 Expanded Access to Investigational Drugs for Treatment Use Rule NFR-Notice of Final Rule 2009-08-13T04:00:00Z 2009 8 2009-08-13T04:00:00Z   2015-06-02T18:01:51Z E9-19005 0 0 0900006480a084e7
FDA-2006-N-0238-0019 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 Letter from Cancer Leadership Council (CLC) to FDA /CDER Other Letter(s) 2008-12-16T05:00:00Z 2008 12 2008-12-16T05:00:00Z   2025-04-11T22:27:16Z   0 0 0900006480744556
FDA-2006-N-0238-0018 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 OMB Changes of the Proposed Rule FDA Regulations Policy and Management Staff to the Division of Dockets Management Supporting & Related Material Reference (internal unless indicated) 2008-10-14T04:00:00Z 2008 10     2025-04-14T17:07:08Z   0 0 0900006480456b60
FDA-2006-N-0238-0017 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 Reference 1 OMB Changes of FDA Regulations Policy and Management Staff to the Division of Dockets Management Supporting & Related Material Reference (internal unless indicated) 2008-10-10T04:00:00Z 2008 10     2025-04-14T16:59:59Z   0 0 0900006480456cc2
FDA-2006-N-0238-0008 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 Attachment 1 Creation and Development of the Public Service Orphan Drug Human Botulism Immune Globulin re Comment from California Department of Health Services Supporting & Related Material C-Comment (Supporting and Related Material) 2007-03-19T04:00:00Z 2007 3     2025-04-14T16:49:35Z   0 0 0900006480456e00
FDA-2006-N-0238-0010 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 Attachment 2 Human Botulism Immune Globulin for the Treatment of Infant Botulism re Comment from California Department of Health Services Supporting & Related Material C-Comment (Supporting and Related Material) 2007-03-19T04:00:00Z 2007 3     2025-04-14T16:50:01Z   0 0 0900006480456e03
FDA-2006-N-0238-0006 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 Memorandum from Office of Policy to the Division of Dockets Management Request for Extension Comment Period Other Memorandum 2007-03-13T04:00:00Z 2007 3 2007-03-12T04:00:00Z   2025-04-11T22:24:04Z   0 0 0900006480456d95
FDA-2006-N-0238-0001 FDA Expanded Access to Investigational Drugs for Treatment Use FDA-2006-N-0238 Expanded Access to Investigational Drugs for Treatment Use Proposed Rule Notice of Proposed Rulemaking (NPRM) 2006-12-14T00:00:00Z 2006 12 2006-12-14T05:00:00Z 2007-03-15T03:59:59Z 2025-05-21T09:01:14Z 06-9684 0 0 0900006480456c8f

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);